• Glucose-6-Phosphate Dehydrogenase (G6PD) Gene Mutation Analysis
  • Antinuclear Antibody (ANA), Body Fluid
  • Homovanillic Acid (HVA), Random, Urine
  • IGH Somatic Hypermutation Analysis, B-Cell Chronic Lymphocytic Leukemia (B-CLL)
  • Zinc, Serum
  • Avantect Ovarian Cancer Test
  • Proinsulin, Intact
  • Androgen Receptor (AR) Gene Mutation Analysis
  • Cystic Fibrosis (CFTR) Gene Mutation Analysis
  • Lysergic Acid Diethylamide, Urine
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Prosigna Breast Cancer Prognostic Gene Signature
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Prosigna Breast Cancer Prognostic Gene Signature
Medical Test

References
Access to Prosigna Breast Cancer Prognostic Gene Signature is restricted.
Loading...